Parsabiv
Chemical Name | etelcalcetide |
Dosage Form | Injection (intravenous; 2.5 mg/0.5 ml, 5 mg/ml, 10 mg/2 ml) |
Drug Class | Receptor agonists |
System | Endocrine |
Company | KAI Pharmaceuticals, Inc. |
Approval Year | 2017 |
Indication
- To treat secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis.